Tag Archives: Virchow Biotech to Make 200 Million Doses of Russia’s Sputnik V

Virchow Biotech to Make 200 Million Doses of Russia’s Sputnik V

Virchow Biotech, an India-based pharmaceutical company has signed an agreement with the Russian COVID-19 vaccine ‘Sputnik V’ for the production of 200 million vaccine doses. The development of the Russian vaccine is funded by the Russian Direct Investment Fund (RDIF) and it has also confirmed the partnership with an Indian manufacturer. RDIF has planned the […]